Skip to main content

Effects of Canrenone on Na+, K+ ATPase Activity, Arterial Pressure and Plasma Potassium Concentration in Uremic Hemodialyzed Patients

  • Chapter
  • 156 Accesses

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 252))

Abstract

Canrenone is the main active metabolite1 of the diuretic and antihypertensive drugs spironolactone and canrenoate-K, and competes with aldosterone for a common cytosolic receptor in distal and collecting tubules of the nephron.2 In addition it has recently been demonstrated that canrenone in vitro may directly interfere with ouabain-sensitive Na+,K+ pump (Na+,K+ adenosine triphosphatase), acting as a partial agonist at the digitalis receptor site. 3,4 Moreover Garay et al.4 showed that canrenone is able to restimulate in vitro the Na+,K+ pump of human red blood cells (RBC) blocked by high concentrations of ouabain.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. W. Sadéé M. Dagcioglu, and R. J. Schroder, Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans, Pharmacol. Exp. Ther. 185: 686–695 (1973).

    Google Scholar 

  2. D. Marver and J. P. Kokko, Renal target sites and the mechanism of action of aldosterone. Min. Electrolyte Metab. 9: 1–18 (1983).

    CAS  Google Scholar 

  3. P. Finotti and P. Palatini, Canrenone as a partial agonist at the digitalis receptor site of sodium potassium activated adenosine triphosphatase, J. Pharmacol. Exp. Ther. 217: 784–790 (1981).

    PubMed  CAS  Google Scholar 

  4. R. P. Garay, J. Diez, C. Nazaret, G. Dagher, and J. P. Abitbol, The interaction of canrenone with the Na+,K+ pump in human red blood cells, Naunyn-Schmiedeberg’s Arch. Pharmacol. 329: 311–315 (1985).

    Article  CAS  Google Scholar 

  5. L. G. Welt, G. R. Sachs, J. J. Macmanus, An ion transport defect in erythrocytes from uremic patients. Trans. Assoc. Am. Phys. 77: 169–181 (1964).

    PubMed  CAS  Google Scholar 

  6. L. G. Welt, E. K. M. Smith, M. J. Dunn, A. Szerwinski, H. Proctor, C. Cole, J. W. Balfe and H. J. Gitelman, Membrane transport defect: the sick cell. Trans, Assoc, Am, Phys, 30: 217–226 (1967).

    Google Scholar 

  7. A. P. Quintanilla, Alteration of Na,K pump in the uremic state. Int. J. Artif. Organs 10: 337–442 (1988).

    Google Scholar 

  8. H. Izumo, S. Izumo, M. DeLuise and J. Flier, Erythrocyte pump in uremia. Acute correction of transport defect by hemodialysis, J. Clin. Invest, 74: 581–588 (1984).

    Article  PubMed  CAS  Google Scholar 

  9. F. Quarello, R. Boero, C. Guarena, C. Rosati, M.C. Deabate, T. Fidelio and G. Piccoli, Red blood cell Na+,K+ pump activity in patients on hemofiltration. Blood Purif. 2: 130–134 (1984).

    Article  Google Scholar 

  10. C. H. Cole, J. W. Balfe and C. G. Welt, Induction of an ouabain sensitive ATPase defect by uremic plasma. Trans. Assoc. Am. Phys. 81: 213–221 (1968).

    PubMed  CAS  Google Scholar 

  11. H. J. Kramer, J. Pennig, D. Klingmüller, J. Kipnowski, K. Glänzer and R. Düsing, Digoxin-like immunoreacting substance(s) in the serum of patients with chronic uremia. Nephron 40: 297–302 (1985).

    Article  PubMed  CAS  Google Scholar 

  12. J. H. Acosta, Hypertension in chronic renal failure. Kidney Int. 22: 702–712 (1982).

    Article  Google Scholar 

  13. M. P. Blaustein, Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 232: C165-C173 (1977).

    PubMed  CAS  Google Scholar 

  14. J. Fernandez, J. R. Oster and G. O. Perez, Impaired extrarenal disposal of an acute oral potassium load in patients with end stage renal disease on chronic hemodialysis. Min. Electrolyte Metail. 12: 125–129 (1986).

    CAS  Google Scholar 

  15. V. Buckalew and K. Gruber, Natiuretic hormone, in: “The Kidney in Liver disease”, M. Epstein, ed., Elsevier Biomedical, New York (1983), p. 479–499.

    Google Scholar 

  16. J. M. Krzezinsky and G. Rorive, (letter), N. Engl. J. Med. 309: 987–988 (1983).

    Article  Google Scholar 

  17. F. Quarello, R. Boero, C. Guarena, C. Rosati, G. Giraudo, F. Giacchino and G. Piccoli, Acute effects of hemodialysis on erythrocyte sodium fluxes in uremic patients. Nephron 41: 22–25 (1985).

    Article  PubMed  CAS  Google Scholar 

  18. G. Deray, M. G. Pernollet, M. A. Devynck, J. Zingraff, A. Touam, J. Rosenfeld and P. Meyer, Plasma digitalis-like activity in essential hypertension or end-stage renal disease. Hypertension 8: 632–638 (1986).

    Article  PubMed  CAS  Google Scholar 

  19. R. Boero, F. Quarello, C. Guarena, C. Rosati and G. Piccoli, Effects of an intravenous saline load on erythrocyte sodium transport in normal human subjects, Clin. Sci. 69: 709–712 (1985).

    PubMed  CAS  Google Scholar 

  20. F. Quarello, R. Boero, C. Guarena, M. C. Deabate, M. C. Forneris, C. Rosati, B. Rolando and G. Piccoli, II canrenone previene 1’inibizione della Na+,K+ pompa indotta dall’ espansione del volume extracellulare, ia: “Nefrologia Dialisi Trapianto”, C. Giordano and N. DeSanto, eds., Wichtig, Milano (1986), p. 431–434.

    Google Scholar 

  21. R. Boero, C. Guarena, M. C. Deabate, B. Rolando, C. Rosati, F. Quarello and G. Piccoli, Erythrocyte Na+,K+ pump inhibition following saline infusion in essential hypertensive subjects: effects of canrenone administration. Int. J. Cardiology (in press).

    Google Scholar 

  22. G. Pati, E. Niutta, M. G. Tripodi, C. Barlassina, D. Cusi and G. Bianchi, Inibizione dell’azione delle sostanze endogene ad attivitè ouabaino-simile da parte del canrenoato di K nell’ ipertensione arteriosa essenziale, in: “Atti XXVI Congresso Nazionale Societa Italiana di Nefrologia”, F. Mastrangelo, S. Rizzelli, V. De Blasi, L. Alfonso and D. Brancaccio, eds. Wichtig, Milano (1985), p. 247–250.

    Google Scholar 

  23. H. E. de Wardener and G. A. MacGregor, The natriuretic hormone and essential hypertension. Lancet 26: 1450–1454 (1982).

    Article  Google Scholar 

  24. M. De Mendonca, M. L. Grichois, M. G. Pernollet, B. Thorman, P. Meyer, M. A. Devynck and R. Garay, Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present, J. Hypertension 3 (suppl. 3): 73–75 (1985).

    Google Scholar 

  25. M. L. Grichois, M. De Mendonca, I. Wauquier, M. G. Pernollet, B. Thorman, M. A. Devynck, P. Meyer and R. P. Garay, La canrénone: un antihypertenseur efficace dans le modèle expérimental d’hypertension Où le transport actif du sodium est diminué. Arch. Mai. Coeur 6: 875–878 (1986).

    Google Scholar 

  26. J. Brod, J. Shaeffer, H. Hengtenberg and T. Kleinschmidt, Investig ations on the Na+,K+ pump in erythrocytes of patients with renal hypertension, Clin. Sci. 66: 351–355 (1984).

    PubMed  CAS  Google Scholar 

  27. R. Boero, C. Guarena, I. M. Berto, M. C. Deabate, C. Rosati, F. Quarello and G. Piccoli, Erythrocyte pump activity and arterial hypertension in uremic dialyzed patients (submitted).

    Google Scholar 

  28. P. Salvati, F. Vaghi, M. Colombo and G. Bianchi, The interaction of canrenone with the Na,K pump in isolated rabbit renal arteries, in: “Abs. Xth Int. Congr. Nephrol.”, London (1987), p. 300.

    Google Scholar 

  29. S. Laurent, P. Hannaert, X. Girard, M. Safar and R. P. Garay. Chronic treatment with canrenone in essential hypertensive patients potentiates the acute pressor effect of ouabain, J. Hypertension 5: S173-S175 (1987).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Quarello, F. et al. (1989). Effects of Canrenone on Na+, K+ ATPase Activity, Arterial Pressure and Plasma Potassium Concentration in Uremic Hemodialyzed Patients. In: Amerio, A., Coratelli, P., Campese, V.M., Massry, S.G. (eds) Drugs, Systemic Diseases, and the Kidney. Advances in Experimental Medicine and Biology, vol 252. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8953-8_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8953-8_38

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8955-2

  • Online ISBN: 978-1-4684-8953-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics